CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
GHRHdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000380
NCT00000380N/ACompleted

Age-Related Sleep Impairment - Treatment w/GHRH

University of Washington·interventional·Posted Nov 3, 1999·Updated Dec 3, 2015

In Brief

A clinical study evaluating GHRH for Sleep Disorders. Completed.

Detailed Summary

The purpose of this study is to examine the effects of giving growth hormone releasing hormone (GHRH) to treat sleep disorders in older men and in older women who are on estrogen replacement therapy (ERT). Many older men and women complain of sleep disturbances. GHRH has been used successfully to treat sleep disorders in young men and may help older men and women. 40 healthy older men and 40 healthy older women on ERT will receive either GHRH or an inactive placebo. An individual may be eligible for this study if he/she is a healthy older man or woman with sleep disturbances, and is on estrogen replacement therapy (women).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSleep Disorders
Countries--

Timeline

N/ACompletedFinished
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 3, 1999
Enrollment StartJun 1, 1996
Primary CompletionJul 1, 2007
TodayJul 2, 2026
Enrollment to primary: 11.1 yearsPosted 26.7 years ago

Interventions

GHRHdrug